Publication date
July 2001
DOI Publisher
Springer Science and Business Media LLC Journal
Current Controlled Trials in Cardiovascular MedicineAbstract
Abstract Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the prevention and treatment of VTE and suggest future directions for research.</p
Add to ORKG